You are here:
Home
NICE Guidance
Conditions and diseases
Cancer
Bladder cancer
Atezolizumab with BCG before surgery (neoadjuvant) for treating non-muscle-invasive bladder cancer [ID6667]
Awaiting development
Reference number:
GID-TA11884
Expected publication date: TBC
Project information
Project documents
Documents
Documents created during the development process.
Topic selection
Topic selection
Back to top